37470-46-5

Basic information

• Product Name: 4-HYDROXY-3-IODOBENZOIC ACID
• Synonyms: BUTTPARK 22\07-100;3-IODO-4-HYDROXYBENZOIC ACID;4-HYDROXY-3-IODOBENZOIC ACID;2-Iodo-4-carboxyphenol;4-Carboxy-2-iodophenol
• CAS NO: 37470-46-5
• Molecular Formula: C₇H₅IO₃
• Molecular Weight: 264.02
• Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts
• Mol File: 37470-46-5.mol
• Article Data: 22

Chemical Properties

• Melting Point: 172-175℃
• Boiling Point: 330 °C at 760 mmHg
• Flash Point: 153.4 °C
• Appearance: /
• Density: 2.155
• Vapor Pressure: 6.86E-05mmHg at 25°C
• Refractive Index: 1.712
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 4-HYDROXY-3-IODOBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-HYDROXY-3-IODOBENZOIC ACID(37470-46-5)
• EPA Substance Registry System: 4-HYDROXY-3-IODOBENZOIC ACID(37470-46-5)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 37470-46-5(Hazardous Substances Data)

Usage

Uses

4-Hydroxy-3-iodobenzoic acidis used for enantioselective cross-electrophile Aryl-Alkenylation of unactivated alkenes.

InChI:InChI=1/C7H5IO3/c8-5-3-4(7(10)11)1-2-6(5)9/h1-3,9H,(H,10,11)

Upstream product

• 1571-72-8 3-amino-4-hydroxybenzoic acid 
• 7732-18-5 water 
• 99-96-7 4-hydroxy-benzoic acid 
• 64-17-5 ethanol 
• 7553-56-2 iodine 
• 618-76-8 3,5-diiodo-4-hydroxybenzoic acid 

Downstream Products

• 10463-17-9 3-iodo-4-hydroxy-5-nitrobenzoic acid 
• 475650-18-1 1-[1-(4-hydroxy-3-iodo-benzoyl)-piperidin-4-yl]-1,4-dihydro-benzo[d][1,3]oxazin-2-one 
• 440111-01-3 3-diphenylphosphino-4-hydroxy-benzoic acid 
• 69703-21-5 methyl 2-(2-hydroxypropan-2-yl)benzofuran-5-carboxylate 
• 190067-53-9 methyl 2-phenylbenzo[b]furan-5-carboxylate 
• 501892-55-3 methyl 4-hydroxy-3-((trimethylsilyl)-ethynyl)benzoate 
• 108763-47-9 5-(methoxycarbonyl)benzo[b]furan 
• 105401-94-3 ethyl 4-methoxy-3,5-dimethylbenzoate 

Relevant articles and documents

Active Site Binding Is Not Sufficient for Reductive Deiodination by Iodotyrosine Deiodinase

The minimal requirements for substrate recognition and turnover by iodotyrosine deiodinase were examined to learn the basis for its catalytic specificity. This enzyme is crucial for iodide homeostasis and the generation of thyroid hormone in chordates. 2-

Imidazole-containing condensed tricyclic compound and application thereof

The invention discloses an imidazole-containing condensed tricyclic compound adopting the structure as shown in the formula (I) or pharmaceutically acceptable salts, stereisomers or prodrug molecules thereof. The imidazole-containing condensed tricyclic compound has the IDO1 activity regulation function, can enhance T-cell activation through blocking immune checkpoints IDO1, is used for treating IDO1-mediated immunosuppression, and therefore, can become an effective medicine for treating malignant tumors. When used together with checkpoint protein anti-body drugs or other anti-cancer drugs, the imidazole-containing condensed tricyclic compound can enhance the anti-cancer effect. Meanwhile, the imidazole-containing condensed tricyclic compound has the potential of effectively treating IDO1 abnormity related immunosuppressive diseases and has a high application value.

Heterocyclic modulators of cannabinoid receptors

Heterocyclic compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are a